The authors found that TRG16 expression was significantly downregulated in breast cancer (BC) tissues compared with adjacent tissues and BC patients with lower expression of TRG16 had a worse prognosis.
[Molecular and Cellular Biochemistry]
TRG16, Targeted by miR-765, Inhibits Breast Cancer Stem Cell-Like Properties via Regulating the NF-κB Pathway
